Glial Cell Line‐Derived Neurotrophic Factor: Potential for Otoprotection

ABSTRACT: Sensorineural hearing loss results from the degeneration of hair cells and/or auditory neurons in the cochlea of the inner ear. BDNF and NT‐3 were shown to support survival of auditory neurons both in vitro and in vivo. Cochlea from P3‐P4 rats were cultured as floating explants and hair cells in the organ of Corti were identified by phalloidin‐FITC immunostaining. Treatment with cisplatin (35 μg/mL) or neomycin (0.6 mM) resulted in 21.2 ± 6.0% and 7.4 ± 4.7% surviving hair cells, respectively, after 3 days in culture. GDNF, added together with the ototoxins, increased their number to 46.7% and 37.4%, respectively. In cultures of dissociated cochlea from 4‐week‐old rat, cisplatin (5 mg/mL) added 24 h after seeding resulted in only 6.1 ± 1.2% surviving neurons. However, when cisplatin was added together with GDNF (10 ng/mL), 32.8 ± 1.0% of the neurons survived. The efficacy of GDNF in animal models of ototoxicity was tested next. Guinea pigs were pretreated with GDNF in one ear, delivered either by infusion into the inner ear (scala tympani) with Alzet minipumps (50 ng/mL at a 0.5 μL/h), or injected into the middle ear (120 μL at 1 mg/mL) through the tympanic membrane. The ear that did not receive GDNF always served as control. Ototoxicity was induced systemically either by intraperitoneal cisplatin injections (1 mg/kg/day for 15 days or two injections of 7.5 mg/kg at a 5‐day interval or by a combination of kanamycin (200–300 mg/kg, administered subcutaneously) and ethacrinic acid (40 mg/kg, intravenous). It was found that the number of surviving hair cells in GDNF‐treated ears was about twice that of control ears in animals exposed to the ototoxins. The transducing GDNF receptor (ret) is expressed in the inner ear.

[1]  J. Kasperbauer,et al.  TGFα Passage Through Guinea Pig Round Window Membrane , 1997, Otolaryngology–Head and Neck Surgery.

[2]  L. Olson,et al.  Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs , 1997, Experimental Brain Research.

[3]  B. Hoffer,et al.  Glial Cell Line-Derived Neurotrophic Factor Protects against Ischemia-Induced Injury in the Cerebral Cortex , 1997, The Journal of Neuroscience.

[4]  Marcos V. Goycoolea,et al.  Round window membrane. Structure function and permeability: A review , 1997, Microscopy research and technique.

[5]  P. Ernfors,et al.  Aminoglycoside excitement silences hearing , 1996, Nature Medicine.

[6]  C. Berlin,et al.  N–Methyl–D–aspartate antagonists limit aminoglycoside antibiotic–induced hearing loss , 1996, Nature Medicine.

[7]  L. Olson,et al.  Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system , 1996, Cell and Tissue Research.

[8]  Wulfram Gerstner,et al.  A neuronal learning rule for sub-millisecond temporal coding , 1996, Nature.

[9]  I. Fariñas,et al.  Renal and neuronal abnormalities in mice lacking GDNF , 1996, Nature.

[10]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[11]  J. Louis,et al.  GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF , 1996, Cell.

[12]  E. Arenas,et al.  Functional receptor for GDNF encoded by the c-ret proto-oncogene , 1996, Nature.

[13]  B. Ponder,et al.  GDNF signalling through the Ret receptor tyrosine kinase , 1996, Nature.

[14]  Barbara Canlon,et al.  Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3 , 1996, Nature Medicine.

[15]  Eric M. Priuska,et al.  Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. , 1995, Biochemical pharmacology.

[16]  A. Davies,et al.  GDNF is an age-specific survival factor for sensory and autonomic neurons , 1995, Neuron.

[17]  Yihai Cao,et al.  The site of action of neuronal acidic fibroblast growth factor is the organ of Corti of the rat cochlea. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R R Stewart,et al.  Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  A. Granholm,et al.  Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons , 1995, The Journal of comparative neurology.

[20]  Q. Yan,et al.  In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons , 1995, Nature.

[21]  R. Oppenheim,et al.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF , 1995, Nature.

[22]  R. Vandlen,et al.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.

[23]  C. Henderson,et al.  GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. , 1994, Science.

[24]  G. Moonen,et al.  Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. , 1994, Neuroreport.

[25]  Alfred L. Nuttall,et al.  Osmotic pump implant for chronic infusion of drugs into the inner ear , 1993, Hearing Research.

[26]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[27]  V. Schweitzer.  Cisplatin‐Induced Ototoxicity: The Effect of Pigmentation and Inhibitory Agents , 1993 .

[28]  Josef M. Miller,et al.  Chronic drug infusion into the scala tympani of the guinea pig cochlea , 1992, Journal of Neuroscience Methods.

[29]  B. M. Johnstone,et al.  The ototoxic mechanism of cisplatin , 1990, Hearing Research.

[30]  W. Dreschler,et al.  High Frequency Audiometry in Prospective Clinical Research of Ototoxicity Due to Platinum Derivatives , 1988, The Annals of otology, rhinology, and laryngology.

[31]  G. Cooper,et al.  ret transforming gene encodes a fusion protein homologous to tyrosine kinases , 1987, Molecular and cellular biology.

[32]  C. G. Wright,et al.  Ototoxicity of low‐ and moderate‐dose cisplatin , 1985, Cancer.

[33]  J. Ritz,et al.  Activation of a novel human transforming gene, ret, by DNA rearrangement , 1985, Cell.

[34]  Y Nomura,et al.  Otological significance of the round window. , 1984, Advances in oto-rhino-laryngology.

[35]  R. Kimura,et al.  Distribution of HRP in the inner ear after injection into the middle ear cavity. , 1984, Acta oto-laryngologica.

[36]  D. Bocangel,et al.  Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for sensory neurons: comparison with the effects of the neurotrophins. , 1997, Journal of neurobiology.

[37]  V. Schweitzer.  Cisplatin‐Induced Ototoxicity: The Effect of Pigmentation and Inhibitory Agents , 1993, The Laryngoscope.

[38]  S. Juhn,et al.  Relationship between antigen levels in middle ear and antigen passage through round window membrane in antigen-induced otitis media. , 1989, Acta oto-laryngologica. Supplementum.

[39]  S. Juhn,et al.  Round window membrane permeability to human serum albumin in antigen-induced otitis media. , 1988, American journal of otolaryngology.

[40]  J. C. de Groot,et al.  Human cochlear pathology in aminoglycoside ototoxicity--a review. , 1987, Acta oto-laryngologica. Supplementum.

[41]  L. Rybak,et al.  Drug ototoxicity. , 1986, Annual review of pharmacology and toxicology.

[42]  R. D. Brown,et al.  Link between functional and morphological changes in the inner ear--functional changes produced by ototoxic agents and their interactions. , 1985, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[43]  Y. Nakai,et al.  Ototoxicity of the anticancer drug cisplatin. An experimental study. , 1982, Acta oto-laryngologica.

[44]  F. O. Black,et al.  Aminoglycoside-induced cochlear pathology in man. , 1981, Acta oto-laryngologica. Supplementum.

[45]  Y. Nakai,et al.  Ototoxicity of the Anticancer Drug Cisplatin , 1981 .